Literature DB >> 1659797

A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus.

C D Bayliss1, R W Peters, J K Cook, R L Reece, K Howes, M M Binns, M E Boursnell.   

Abstract

The coding sequences of VP2 from a virulent strain, 52/70, of infectious bursal disease virus (IBDV) were excised from a cDNA clone and inserted into a fowlpox plasmid insertion vector. The resulting plasmid, pIBD 1, was used to construct a recombinant fowlpox virus, fpIBD 1, which expressed VP 2 as a beta-galactosidase fusion protein. Chickens vaccinated with fpIBD 1 at 1 and 14 days of age, were challenged at 28 days with either IBDV strain 52/70 or the highly virulent strain CS 89. These chickens were protected against mortality, but not against damage to the bursa of Fabricius. The protection achieved by the use of fpIBD 1 shows that VP 2 is a host protective antigen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659797     DOI: 10.1007/bf01310475

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Comparison of two infectious bursal disease vaccine strains: efficacy and potential hazards in susceptible and maternally immune birds.

Authors:  J C Muskett; I G Hopkins; K R Edwards; D H Thornton
Journal:  Vet Rec       Date:  1979-04-14       Impact factor: 2.695

2.  Loss of virulence in a small plaque mutant of the infectious bursal disease virus.

Authors:  D Cursiefen; I Käufer; H Becht
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus.

Authors:  A A Azad; M N Jagadish; M A Brown; P J Hudson
Journal:  Virology       Date:  1987-11       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus.

Authors:  A A Azad; K J Fahey; S A Barrett; K M Erny; P J Hudson
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

6.  A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV.

Authors:  M E Boursnell; P F Green; A C Samson; J I Campbell; A Deuter; R W Peters; N S Millar; P T Emmerson; M M Binns
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

7.  Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles.

Authors:  H Müller; H Becht
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Fowlpox virus: its structural proteins and immunogens and the detection of viral-specific antibodies by ELISA.

Authors:  A P Mockett; D J Southee; F M Tomley; A Deuter
Journal:  Avian Pathol       Date:  1987       Impact factor: 3.378

9.  Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus.

Authors:  H Becht; H Müller; H K Müller
Journal:  J Gen Virol       Date:  1988-03       Impact factor: 3.891

10.  Antibody to the 32K structural protein of infectious bursal disease virus neutralizes viral infectivity in vitro and confers protection on young chickens.

Authors:  K J Fahey; I J O'Donnell; T J Bagust
Journal:  J Gen Virol       Date:  1985-12       Impact factor: 3.891

View more
  25 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Identification and DNA sequence analysis of the Marek's disease virus serotype 2 genes homologous to the thymidine kinase and UL24 genes of herpes simplex virus type 1.

Authors:  Y Shimojima; H K Jang; M Ono; K Maeda; Y Tohya; T Mikami
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 3.  Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence.

Authors:  M M Nagarajan; F S Kibenge
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

4.  Recombinant canarypox virus expressing the VP2 protein of infectious bursal disease virus induces protection in vaccinated SPF chickens.

Authors:  Flavia Adriana Zanetti; Romina Cardona; Carlos Rodolfo Federico; Silvina Chimeno-Zoth; Gabriela Calamante
Journal:  Virol Sin       Date:  2016-06       Impact factor: 4.327

Review 5.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Expression of VP2 gene protein of infectious bursal disease virus detected in Korea.

Authors:  Toh-Kyung Kim; Sang-Geon Yeo
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

7.  Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.

Authors:  S K Reddy; A Silim; M J Ratcliffe
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Role of the TK+ phenotype in the stability of pigeonpox virus recombinant.

Authors:  C Letellier
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.

Authors:  H G Heine; D B Boyle
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Vaccination with E. coli recombinant empty viral particles of infectious bursal disease virus (IBDV) confer protection.

Authors:  Arie Rogel; Luna Benvenisti; Ilan Sela; Orit Edelbaum; Edna Tanne; Yehoshua Shachar; Yehuda Zanberg; Tanya Gontmakher; Eli Khayat; Yehuda Stram
Journal:  Virus Genes       Date:  2003-10       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.